ERFSF (Eurofins Scientific SE) 1-Year Sharpe Ratio: 0.32 (As of Jul. 12, 2026)


ERFSF Eurofins Scientific SE ERFSF
79 GF Score
Price $80.40
GF Value $78.13
Valuation Fairly Valued
! 7 Warning Signs
View Full Analysis

What is Eurofins Scientific SE 1-Year Sharpe Ratio?

Eurofins Scientific SE ERFSF +0.21% 79 1-Year Sharpe Ratio is 0.32 as of Jul. 12, 2026. GuruFocus rates ERFSF with a GF Score™ of 79/100 and a GF Value™ of $78.13 (Fairly Valued). The stock has 7 warning signs investors should review.

The 1-Year Sharpe Ratio measures the additional return that an investor receives per unit of increase in risk over the past year. As of today (2026-07-12), Eurofins Scientific SE's 1-Year Sharpe Ratio is 0.32.

Eurofins Scientific SE  (OTCPK:ERFSF) 1-Year Sharpe Ratio Explanation

The 1-Year Sharpe Ratio inidicates the risk-adjusted return of an investment over the past year. It is calculated as the annualized result of the average monthly excess return divided by its standard deviation over the past year. The monthly excess return is the monthly investment return minus the monthly risk-free rate (typically the 10-year Treasury Constant Maturity Rate). If the risk-free rate for a specific region is not available, U.S. data is used by default.

The greater a portfolio's Sharpe Ratio, the better its risk-adjusted performance. A negative Sharpe Ratio means the risk-free rate is greater than the portfolio’s historical or projected return, or else the portfolio's return is expected to be negative.

Eurofins Scientific SE 1-Year Sharpe Ratio Related Terms

ERFSF vs TMO, DHR, IDXX: 1-Year Sharpe Ratio Comparison

For the Diagnostics & Research subindustry, Eurofins Scientific SE's 1-Year Sharpe Ratio, along with its competitors' market caps and 1-Year Sharpe Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Eurofins Scientific SE 1-Year Sharpe Ratio vs Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Eurofins Scientific SE's 1-Year Sharpe Ratio distribution charts can be found below:

* The bar in red indicates where Eurofins Scientific SE's 1-Year Sharpe Ratio falls into.


ERFSF
79GF Score
Eurofins Scientific SE ERFSF
1-Year Sharpe Ratio is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Eurofins Scientific SE 1-Year Sharpe Ratio Calculation

The 1-Year Sharpe Ratio measures the performance of an investment such as a stock or portfolio compared to a risk-free asset. A stock / portfolio's 1-Year Sharpe Ratio can be calculated by dividing the difference between the one-year returns of the investment and the risk-free rate, by the standard deviation of the investment returns over one year.

Frequently Asked Questions Learn more about 1-Year Sharpe Ratio →
What does a 1-Year Sharpe Ratio of 0.32 mean?
Eurofins Scientific SE (ERFSF) has a 1-Year Sharpe Ratio of 0.32 as of Jul. 12, 2026. 1-Year Sharpe Ratio measures the additional return that an investor receives per unit of increase in risk. View historical data for Eurofins Scientific SE and its competitors.
Is Eurofins Scientific SE's 1-Year Sharpe Ratio too high?
Eurofins Scientific SE's current 1-Year Sharpe Ratio is 0.32. Overall, Eurofins Scientific SE has a GF Score™ of 79/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Eurofins Scientific SE's 1-Year Sharpe Ratio compare to TMO and DHR?
Eurofins Scientific SE's 1-Year Sharpe Ratio of 0.32 can be compared against companies in the Medical Diagnostics & Research industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 1-Year Sharpe Ratio for a Medical Diagnostics & Research company?
A good 1-Year Sharpe Ratio depends on the Medical Diagnostics & Research industry context. However, 1-Year Sharpe Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 1-Year Sharpe Ratio mean?
A high 1-Year Sharpe Ratio can signal that a stock is expensive relative to its fundamentals. 1-Year Sharpe Ratio measures the additional return that an investor receives per unit of increase in risk. View historical data for Eurofins Scientific SE and its competitors. Eurofins Scientific SE's current 1-Year Sharpe Ratio is 0.32. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Eurofins Scientific SE stock overvalued right now?
Based on GuruFocus' analysis, Eurofins Scientific SE (ERFSF) is currently considered Fairly Valued. The stock's GF Value™ is $78.13, compared to a current price of $80.40 — trading 2.9% above its estimated fair value. The current 1-Year Sharpe Ratio is 0.32. Eurofins Scientific SE's overall GF Score™ is 79/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 1-Year Sharpe Ratio calculated?
1-Year Sharpe Ratio is calculated from a company's financial statements. For Eurofins Scientific SE (ERFSF), the current 1-Year Sharpe Ratio is 0.32 as of Jul. 12, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Eurofins Scientific SE (ERFSF) Overvalued in 2026?

Based on GuruFocus' analysis, Eurofins Scientific SE stock appears to be overvalued. The current stock price of $80.40 is trading 2.9% above its estimated GF Value™ of $78.13. GuruFocus considers Eurofins Scientific SE to be Fairly Valued.

Key valuation signals for ERFSF:

  • 1-Year Sharpe Ratio: 0.32
  • GF Value™: $78.13 vs. price of $80.40 (2.9% above fair value)
  • GF Score™: 79/100 with 7 warning signs

No single metric tells the full story. See the ERFSF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Eurofins Scientific SE Business Description

Address 23 Val Fleuri, Luxembourg, LUX, 1526
Eurofins, headquartered in Luxembourg, is a decentralized network of life sciences companies that provide various analytical tests and laboratory services. These include tests to evaluate the safety, identity, composition, authenticity, purity, origin, and traceability of various biological substances and products. Eurofins operates over 950 laboratories in 61 countries. Its revenue from Europe, North America, and the rest of the world contributes approximately 50%, 40%, and 10% of total revenue, respectively. Its areas of business activity are food, feed, and environmental testing ("life"), biopharmaceutical services, diagnostic services and products, and consumer and technology products testing, which contribute approximately 40%, 30%, 20%, and 10% respectively.
79GF Score

Get the complete analysis for ERFSF

1-Year Sharpe Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$80.40
Price
$78.13
GF Value